OKYO Pharma LTD

Contributing Author

Recent Articles by OKYO Pharma LTD

Jul-17	OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain OKYO GlobeNewswire
Jul-16	OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain OKYO GlobeNewswire
Jun-11	OKYO Pharma to Present at the Bio International Convention OKYO GlobeNewswire
May-19	OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit OKYO GlobeNewswire